20,000+ Scientists & Academics
4,000+ Scientific disciplines
20,000+ Projects posted
Trusted by 3,200+ businesses
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Contact
★★★★★
☆☆☆☆☆
USD 80 /hr
Hire Dr. Adam Edwards
Australia
USD 80 /hr
Profile Summary
Subject Matter Expertise
Services
Work Experience

Research Officer

Sir Charles Gairdner Hospital

July 2018 - Present

Research Officer

Perron Institute for Neurological and Translational Science

July 2018 - Present

Education

Doctorate of Philosophy (PhD) (Health Sciences)

University of Notre Dame Australia

January 2015 - August 2018

Bachelor of Biomedical Science (Hons) (Health Sciences)

University of Notre Dame Australia

March 2011 - December 2014

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy . Journal of Neuroscience Research. 96. (11). p. 1816-1826.
Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs) . Brain Sciences. 8. (8).
Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Edwards, A.B., Knuckey, N.W., et al.(2017). Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury . Translational Neuroscience. 8. (1). p. 147-157.
Meloni, B.P., Milani, D., Cross, J.L., Meloni, B.P., Milani, D., Cross, J.L., Clark, V.W., Edwards, A.B., Anderton, R.S., Blacker, D.J., et al.(2017). Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine–Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats . NeuroMolecular Medicine. 19. (2-3). p. 271-285.
Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P., Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2017). Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model . Molecular and Cellular Biochemistry. 426. (1-2). p. 75-85.
Edwards, A.B., Feindel, K.W., Cross, J.L., Anderton, R.S., Clark, V.W., Knuckey, N.W., Meloni, B.P.(2017). Modification to the Rice-Vannucci perinatal hypoxic-ischaemic encephalopathy model in the P7 rat improves the reliability of cerebral infarct development after 48 hours . Journal of Neuroscience Methods. 288. p. 62-71.
Meloni, B.P., Brookes, L.M., Clark, V.W., Cross, J.L., Edwards, A.B., Anderton, R.S., Hopkins, R.M., Hoffmann, K., Knuckey, N.W.(2015). Poly-arginine and arginine-rich peptides are neuroprotective in stroke models . Journal of Cerebral Blood Flow and Metabolism. 35. (6). p. 993-1004.